Nacho Abia News Today

Daniel Segarra: Hello, everyone, and welcome to Grifols Conference Call. Today, we will be sharing a business update on our first quarter financial results.

Grifols, a global manufacturer of plasma-based medicines headquartered in Barcelona, Spain, held a celebration to mark 50 years in Clayton, NC.Grifols acquired the Johnston County facility in 2011 from Talecris Biotherapeutics, turning Grifols into a top-three plasma-sector powerhouse. 

/PRNewswire/ -- Olympus, a leading global MedTech company providing innovative solutions for medical and surgical procedures, announced today the appointment...

Current leader Nacho Abia is leaving OCA at the end of this month to take over as CEO at Grifols, a Barcelona-based pharmaceutical company.

The change in leadership at the partnership -- an organization that promotes regional goals -- reflects how the local economy has become more global.

BARCELONA (Reuters) -Spanish drug maker Grifols' top executive Thomas Glanzmann said on Thursday he will become non-executive chairman in 2025 as part of the beleaguered company's management overhaul. Glanzmann, who is currently both chief executive and executive chairman, had said earlier this month he would leave the CEO job on April 1, but remain executive chairman afterwards. Grifols shares on Spain's blue-chip index <.IBEX> were down 6.5% to 10.9 euros per share s...

Renta 4| Grifols (GRF) has announced the appointment of Nacho Abia as the new CEO, replacing Thomas Glanzmann who will continue in the role of executive

Renta 4| Grifols (GRF) has announced the appointment of Nacho Abia as the new CEO, replacing Thomas Glanzmann who will continue in the role of executive

Olympus Corp. of the Americas has gone through plenty of ups and downs in recent years, but one of the constants has been its President and CEO Nacho Abia.